Cargando…
LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
Autores principales: | Grivas, P., Warner, J., Shyr, Y., Shah, D., Rubinstein, S.M., Kuderer, N.M., Choueiri, T.K., Rivera, D., Painter, C., Thompson, M.A., Peters, S., Desai, A., Khaki, A.R., Pennell, N.A., Hawley, J., Halmos, B., Puc, M.M., Lyman, G.H., Rini, B.I., Lopes, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506465/ http://dx.doi.org/10.1016/j.annonc.2020.08.2313 |
Ejemplares similares
-
LBA71 Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
por: Wise-Draper, T.M., et al.
Publicado: (2020) -
Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry
por: Li, Ang, et al.
Publicado: (2020) -
Personalized cancer supportive care in COVID-19 era
por: Lyman, G.H., et al.
Publicado: (2020) -
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
por: Kuderer, Nicole M, et al.
Publicado: (2020) -
Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis
por: Rubinstein, Samuel, et al.
Publicado: (2020)